Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 28, 2017
Quad Technologies has opened a new, larger headquarters and laboratory that allows the company to expand manufacturing capabilities for QuickGel.
read more
Thursday, November 05, 2020
Qualigen has signed a contract with WuXi STA for GMP production of AS1411, Qualigen's lead drug candidate for the treatment of COVID-19 and other viral diseases, for potential clinical trials.
read more
Quanterix announced the relocation of its headquarters to a brand new facility in Billerica, Mass.
read more
Tuesday, November 08, 2022
Quanticate, a global data-focused clinical research organization (CRO), has announced plans for further expansion and new jobs in 2023 as it thrives post-pandemic.
read more
Monday, November 02, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Xediton to develop and commercialize firibastat in Canada.
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Saturday, September 25, 2021
Quell Therapeutics, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced it has entered a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult). The ...
read more
Friday, November 15, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.
read more
Quotient Clinical, the Translational Pharmaceutics Company, has announced the extension of its Translational Pharmaceutics™ platform into patient-focused cancer drug development. Quotient will employ its real-time, flexible manufacturing capabilities...
read more
Thursday, February 11, 2021
Quotient Sciences has acquired Arcinova, a U.K.-based multiservice CDMO.
read more
Friday, November 17, 2017
Quotient Sciences has acquired Pharmaterials, a contract development and manufacturing organization.
read more
Quotient Sciences, the drug development and manufacturing accelerator, announced a £6.3 million-pound investment in its recently acquired manufacturing facility in Alnwick, U.K. The investment will significantly expand Quotient’s drug substance ...
read more
Thursday, February 17, 2022
Quotient Sciences has integrated drug substance into its flagship Translational Pharmaceutics® platform. The newly integrated service unites drug substance, drug product and clinical testing activities all within a unified organization and under a ...
read more
Tuesday, October 16, 2018
Quotient Sciences announces an expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa.
read more
Quotient Sciences, a drug development and manufacturing accelerator, completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs through the ...
read more